Literature DB >> 20842648

Birth defects surveillance in Florida: infant death certificates as a case ascertainment source.

Jean Paul Tanner1, Jason L Salemi, Kimberlea W Hauser, Jane A Correia, Sharon M Watkins, Russell S Kirby.   

Abstract

BACKGROUND: Completeness of case ascertainment is a concern for all birth defects registries and generally requires a multisource approach. Using infant death certificates as one case ascertainment source may identify cases of birth defects that would have otherwise been missed. We sought to examine the utility of adding infant death certificates to the Florida Birth Defect Registry's (FBDR) case ascertainment methods and to determine what factors are associated with the registry's failure to capture infants that die from birth defects.
METHODS: FBDR cases from 1999 to 2006 were matched to a statewide linked birth-infant death file. Descriptive statistics were used to assess the FBDR's ability to capture infants with a birth defect-related cause of death (COD) and identify conditions most commonly missed. Factors associated with the FBDR's failure to capture an infant who died from a birth defect during the first year of life were identified with logistic regression models.
RESULTS: There were 2558 (21.1%) infant deaths with birth defects listed as the underlying or an associated COD, of which the FBDR captured 73.3%. Most often missed defects included malformation of the coronary vessels, lung hypoplasia/dysplasia, anencephaly, and unspecified congenital malformations. Logistic regression identified gestational age/birth weight, age at death, autopsy decision, plurality, adequacy of prenatal care, and maternal nativity as factors associated with the FBDR's failure to capture an infant with a birth defect-related COD.
CONCLUSIONS: Although the overall potential contribution of infant death certificates to the FBDR is small, this source contributes to the prevalence of specific defects.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20842648     DOI: 10.1002/bdra.20718

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  6 in total

1.  A quality assessment of reporting sources for microcephaly in Utah, 2003 to 2013.

Authors:  Amy Steele; Jane Johnson; Amy Nance; Robert Satterfield; C J Alverson; Cara Mai
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

2.  Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection?

Authors:  Cora Peterson; April Dawson; Scott D Grosse; Tiffany Riehle-Colarusso; Richard S Olney; Jean Paul Tanner; Russell S Kirby; Jane A Correia; Sharon M Watkins; Cynthia H Cassell
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09-02

3.  Breech presentation at delivery: a marker for congenital anomaly?

Authors:  D Mostello; J J Chang; F Bai; J Wang; C Guild; K Stamps; T L Leet
Journal:  J Perinatol       Date:  2013-10-24       Impact factor: 2.521

4.  A comparison of two surveillance strategies for selected birth defects in Florida.

Authors:  Jason L Salemi; Jean Paul Tanner; Sara Kennedy; Suzanne Block; Marie Bailey; Jane A Correia; Sharon M Watkins; Russell S Kirby
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

5.  Global prevalence of congenital anencephaly: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Reza Fatahian; Payam Mohammadi; Adibeh Rahmani; Niloofar Darvishi; Mona Keivan; Shamarina Shohaimi; Masoud Mohammadi
Journal:  Reprod Health       Date:  2022-10-17       Impact factor: 3.355

6.  Impact evaluation of Zika epidemic on congenital anomalies registration in Brazil: An interrupted time series analysis.

Authors:  Enny S Paixão; Moreno S Rodrigues; Luciana L Cardim; Juliane F Oliveira; Catharina L C; Maria da Conceição N Costa; Maurício L Barreto; Laura C Rodrigues; Liam Smeeth; Roberto F S Andrade; Wanderson K Oliveira; Maria Glória Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2019-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.